Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

ClinicalTrials.gov ID: NCT06710132

Public ClinicalTrials.gov record NCT06710132. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 2:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PROCEADE PanTumor: A Phase 1b/2, Multicenter, Open-Label Study of Anti-CEACAM5 Antibody-Drug Conjugate M9140 in Participants With Advanced Solid Tumors (Master Protocol)

Study identification

NCT ID: NCT06710132
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: EMD Serono Research & Development Institute, Inc.; Industry
Enrollment: 250 participants

Conditions and interventions

Conditions

Interventions

M9140 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 28, 2025
Primary completion: Dec 22, 2027
Completion: Dec 22, 2027
Last update posted: Apr 28, 2026

2025 – 2027

United States locations

U.S. sites: 8
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of California - Los Angeles - 300208353	Santa Monica	California	90404	Recruiting
Providence Medical Foundation	Santa Rosa	California	95403	Recruiting
Georgetown University - Lombardi Comprehensive Cancer Center - 1134847	Washington D.C.	District of Columbia	20007	Active, not recruiting
D&H Cancer Research Center	Margate	Florida	33063	Recruiting
Prisma Health Cancer Institute, ITOR, CRU	Greenville	South Carolina	29605	Recruiting
Baptist Cancer Center	Memphis	Tennessee	38120	Recruiting
The University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
NEXT Virginia	Fairfax	Virginia	22031	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06710132, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 28, 2026 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06710132 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →